BridgeBio Pharma (BBIO) Reports Q1 Loss, Tops Revenue Estimates

• click to rate

  Posted by Two Blokes 7 hours ago - Filed in Stock - 0 views
  
  BridgeBio Pharma (BBIO) came out with a quarterly loss of $0.88 per share versus the Zacks Consensus Estimate of a loss of $1. This compares to loss of $0.05 per share a year ago.